|
Drug Indication Criteria
|
|
“Any duplicate drug class prescription”
|
2 (0.8)
|
0
|
|
Coagulation System
|
|
“Aspirin plus clopidogrel as secondary stroke prevention, unless the patient has a coronary stent(s) inserted in the previous 12 months or concurrent acute coronary syndrome or has a high grade symptomatic carotid arterial stenosis”
|
3 (1.3)
|
0
|
|
“Aspirin in combination with vitamin K antagonist, direct thrombin inhibitor or factor Xa inhibitors in patients with chronic atrial fibrillation”
|
1 (0.4)
|
0
|
|
“Ticlopidine in any circumstances”
|
5 (2.1)
|
7 (2.9)
|
|
Central Nervous System and Psychotropic Drugs
|
|
“First-generation antihistamines”
|
1 (0.4)
|
1 (0.4)
|
|
Renal System
|
|
“NSAID’s if eGFR < 50 ml/min/1.73m2”
|
1 (0.4)
|
1 (0.4)
|
|
“Metformin if eGFR < 30 ml/min/1.73m2”
|
6 (2.5)
|
4 (1.7)
|
|
Gastrointestinal System
|
|
“Drugs likely to cause constipation in patients with chronic constipation where non-constipating alternatives are available”
|
1 (0.4)
|
0
|
|
“Proton pump inhibitor for uncomplicated peptic ulcer disease or erosive peptic oesophagitis at full therapeutic dosage for > 8 weeks”
|
14 (5.8)
|
13 (5.4)
|
|
Respiratory System
|
|
“Anti-muscarinic bronchodilators with a history of narrow-angle glaucoma or bladder outflow”
|
2 (0.8)
|
0
|
|
Musculoskeletal System
|
|
“Long-term NSAID or colchicine (> 3 months) for chronic treatment of gout where there is no contraindication to a xanthine-oxidase inhibitor”
|
2 (0.8)
|
1 (0.4)
|
|
Endocrine System
|
|
“Sulphonylureas with a long duration of action with type 2 diabetes mellitus”
|
1 (0.4)
|
0
|
|
“Beta-blockers in diabetes mellitus with frequent hypoglycaemic episodes”
|
10 (4.2)
|
4 (1.7)
|
|
Drugs that predictably increase the risk of falls in older people
|
|
“Vasodilator drugs with persistent postural hypotension”
|
23 (9.6)
|
24 (10%)
|
|
Analgesic Drugs
|
|
“Use of regular opioids without concomitant laxative”
|
0
|
4 (1.7)
|
